CDTX
Price:
$221.38
Market Cap:
$5.61B
Cidara Therapeutics, Inc. is a biotechnology company specializing in the creation, advancement, and commercialization of extended-duration anti-infective drugs. Their mission targets the prevention and treatment of infectious diseases and certain cancers within the U.S. Their primary therapeutic candidate, rezafungin acetate, is an innovative echinocandin antifungal designed to combat and avert severe fungal infections such as candidemia and invasive candidiasis, conditions known for their high fatality rates. Additionally, Cidara utilizes its Cloudbreak platform to engineer conjugated therapies aimed at preventing and treating influenza as well as various other viral illnesses, including re...[Read more]
Industry
Biotechnology
IPO Date
2015-04-15
Stock Exchange
NASDAQ
Ticker
CDTX
According to Cidara Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -19.77. This represents a change of 384.02% compared to the average of -4.08 of the last 4 quarters.
The mean historical PE Ratio of Cidara Therapeutics, Inc. over the last ten years is -2.48. The current -19.77 PE Ratio has changed 79.74% with respect to the historical average. Over the past ten years (40 quarters), CDTX's PE Ratio was at its highest in in the March 2023 quarter at 8.29. The PE Ratio was at its lowest in in the June 2025 quarter at -7.36.
Average
-2.48
Median
-1.85
Minimum
-7.34
Maximum
-1.01
Discovering the peaks and valleys of Cidara Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 565.50%
Maximum Annual PE Ratio = -1.01
Minimum Annual Increase = -66.80%
Minimum Annual PE Ratio = -7.34
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -1.01 | -66.80% |
| 2023 | -3.03 | 92.38% |
| 2022 | -1.57 | 0.36% |
| 2021 | -1.57 | 36.03% |
| 2020 | -1.15 | -58.80% |
| 2019 | -2.80 | 171.55% |
| 2018 | -1.03 | -51.76% |
| 2017 | -2.14 | -31.74% |
| 2016 | -3.13 | -57.38% |
| 2015 | -7.34 | 565.50% |
The current PE Ratio of Cidara Therapeutics, Inc. (CDTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-1.87
5-year avg
-1.67
10-year avg
-2.48
Cidara Therapeutics, Inc.’s PE Ratio is less than Mineralys Therapeutics, Inc. (-12.01), greater than Adaptive Biotechnologies Corporation (-53.54), less than Scholar Rock Holding Corporation (-13.72), less than IDEAYA Biosciences, Inc. (-19.77), less than Zai Lab Limited (-11.15), greater than Beam Therapeutics Inc. (-53.34), less than Catalyst Pharmaceuticals, Inc. (17.43), greater than Legend Biotech Corporation (-20.54), less than Disc Medicine, Inc. (-10.66), less than Agios Pharmaceuticals, Inc. (-4.71),
| Company | PE Ratio | Market cap |
|---|---|---|
| -12.01 | $1.63B | |
| -53.54 | $2.81B | |
| -13.72 | $5.67B | |
| -19.77 | $2.95B | |
| -11.15 | $2.04B | |
| -53.34 | $3.51B | |
| 17.43 | $3.84B | |
| -20.54 | $5.17B | |
| -10.66 | $2.70B | |
| -4.71 | $2.03B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cidara Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cidara Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Cidara Therapeutics, Inc.'s PE Ratio?
How is the PE Ratio calculated for Cidara Therapeutics, Inc. (CDTX)?
What is the highest PE Ratio for Cidara Therapeutics, Inc. (CDTX)?
What is the 3-year average PE Ratio for Cidara Therapeutics, Inc. (CDTX)?
What is the 5-year average PE Ratio for Cidara Therapeutics, Inc. (CDTX)?
How does the current PE Ratio for Cidara Therapeutics, Inc. (CDTX) compare to its historical average?